A re-brand for an Oxford University based biotechnology company, called NeuroBio, whose focus is the early onset treatment of Alzheimer's.

Our goal, at BMB London, was to introduce just the right amount of fun for the corporate audience and to also bring them in line with their more modern competitors. The identity’s new look and feel was rolled out, primarily, over their website, medicinal packaging and staff uniforms.